MDXG MIMEDX GROUP, INC.

Nasdaq mimedx.com


$ 7.28 $ 0.21 (2.92 %)    

Thursday, 30-Oct-2025 16:11:03 EDT
QQQ $ 634.13 $ 0.00 (0 %)
DIA $ 475.22 $ 0.00 (0 %)
SPY $ 684.90 $ 0.00 (0 %)
TLT $ 90.24 $ 0.00 (0 %)
GLD $ 368.38 $ 0.00 (0 %)
$ 7.4
$ 7.68
$ 7.04 x 41
$ 7.79 x 111
-- - --
$ 5.79 - $ 10.14
3,448,170
na
1.1B
$ 1.46
$ 26.84
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-29-2025 09-30-2025 10-Q
2 07-30-2025 06-30-2025 10-Q
3 04-30-2025 03-31-2025 10-Q
4 02-26-2025 01-01-1970 10-K
5 10-30-2024 09-30-2024 10-Q
6 07-31-2024 06-30-2024 10-Q
7 04-30-2024 03-31-2024 10-Q
8 02-28-2024 12-31-2023 10-K
9 10-30-2023 09-30-2023 10-Q
10 08-01-2023 06-30-2023 10-Q
11 05-02-2023 03-31-2023 10-Q
12 02-28-2023 12-31-2022 10-K
13 11-02-2022 09-30-2022 10-Q
14 08-02-2022 06-30-2022 10-Q
15 05-03-2022 03-31-2022 10-Q
16 02-28-2022 12-31-2021 10-K
17 11-02-2021 09-30-2021 10-Q
18 08-03-2021 06-30-2021 10-Q
19 04-28-2021 03-31-2021 10-Q
20 03-08-2021 12-31-2020 10-K
21 11-04-2020 09-30-2020 10-Q
22 08-04-2020 06-30-2020 10-Q
23 07-06-2020 03-31-2019 10-Q
24 07-06-2020 06-30-2019 10-Q
25 07-06-2020 09-30-2019 10-Q
26 07-06-2020 12-31-2019 10-K
27 07-06-2020 03-31-2020 10-Q
28 03-17-2020 12-31-2018 10-K
29 10-31-2017 09-30-2017 10-Q
30 07-31-2017 06-30-2017 10-Q
31 05-01-2017 03-31-2017 10-Q
32 03-01-2017 12-31-2016 10-K
33 11-08-2016 09-30-2016 10-Q
34 08-02-2016 06-30-2016 10-Q
35 05-10-2016 03-31-2016 10-Q
36 02-29-2016 12-31-2015 10-K
37 11-06-2015 09-30-2015 10-Q
38 08-07-2015 06-30-2015 10-Q
39 05-01-2015 03-31-2015 10-Q
40 03-13-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mimedx-group-q3-adj-eps-015-beats-007-estimate-sales-113725m-beat-94144m-estimate

MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.07 by...

 cantor-fitzgerald-maintains-overweight-on-mimedx-group-raises-price-target-to-12

Cantor Fitzgerald analyst Ross Osborn maintains MiMedx Group (NASDAQ:MDXG) with a Overweight and raises the price target fro...

 mimedx-group-and-vaporox-collaborate-to-co-promote-and-co-market-their-wound-care-offerings

MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") and Vaporox, Inc. ("Vaporox") today jointl...

 cantor-fitzgerald-reiterates-overweight-on-mimedx-group-maintains-11-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates MiMedx Group (NASDAQ:MDXG) with a Overweight and maintains $11 price target.

 mimedx-group-form4-filing-shows-ceo-joseph-capper-bought-200000-shares-of-stock-at-an-average-price-of-634share

- SEC Filing

 mimedx-group-q1-adj-eps-006-inline-sales-8820m-beat-8620m-estimate

MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. This is a 1...

 cantor-fitzgerald-reiterates-overweight-on-mimedx-group-maintains-13-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates MiMedx Group (NASDAQ:MDXG) with a Overweight and maintains $13 price target.

 mimedx-group-q4-adj-007-inline-sales-9291m-beat-8942m-estimate

MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.07 per share which met the analyst consensus estimate. This is a 7...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION